Search Results
Dec 11, 2025, 09:00 ET Volition Solves Liquid Biopsy's "Needle in a Haystack" Problem; Achieves 180-fold (18,000%) Enrichment
accurate detection of cancer is described in the paper."In a first small training cohort of 70 people, including 49 patients with breast, prostate lung or colorectal cancer, analysis of ultrashort transcription factor-bound DNA was able to detect all the patients with cancer (100% sensitivity), including
More news about: VolitionRx Limited
Dec 11, 2025, 08:00 ET HanchorBio Announces Oral Presentation of HCB101 at the ESMO Immuno-Oncology Congress 2025
lymphoma (~89% tumor regression, ≥16 weeks)Stable disease ≥4-9 months across colorectal cancer (CRC), ovarian cancer, non-small cell lung cancer (NSCLC), and sarcomaCombination Therapy (HCB101-201; NCT06771622)Well-tolerated across gastric cancer (GC), triple-negative
More news about: HanchorBio Inc.
Dec 11, 2025, 07:00 ET Biohaven Presents Clinical Safety and Efficacy Data for BHV-1510, a Next-Generation Trop2 Antibody Drug Conjugate in Combination with Cemiplimab at the 2025 European Society for Medical Oncology (ESMO) Immuno-Oncology Congress
low rates of adverse events attributed to unconjugated payload such as hematological toxicities and diarrhea, and there were no cases of interstitial lung disease, showing a differentiated safety profile of BHV-1510 from other Trop2 ADCsBHV-1510, a highly differentiated Trop2 ADC incorporating
More news about: Biohaven Ltd.
Dec 11, 2025, 06:00 ET "I Have More Energy, Sleep Better, and Better Elimination" - Gundry MD Total Restore Earns Rave Reviews for Transforming Gut Health
cardiothoracic surgeons before leaving his practice to pursue restorative medicine. Currently, he's the medical director at The International Heart and Lung Institute and The Centers for Restorative Medicine in Palm Springs and Montecito, California where he's spent the past 25 years helping people restore
More news about: Gundry MD
Dec 10, 2025, 16:01 ET Nuvalent Appoints Ron Squarer to Board of Directors
leveraging his deep expertise as we advance toward the potential first approval and launch of zidesamtinib for TKI pre-treated ROS1-positive non-small cell lung cancer in 2026."Mr. Squarer brings more than 30 years of proven leadership in oncology drug development and commercialization to the Nuvalent
More news about: Nuvalent, Inc.
Dec 10, 2025, 11:03 ET HealthWell Foundation Opens Fund to Assist Individuals Living with Bronchiectasis
to grow, leading to repeated serious lung infections, causing more damage to airways in the lungs. Airways become scarred and stretched, resulting in the inability to move air in and out. Symptoms may not appear for months or years after the onset of repeated lung infections. Other common comorbidities
More news about: HealthWell Foundation
Dec 10, 2025, 10:09 ET Không gian tinh tế của LEPAS L8: Nơi trú ẩn an yên cho lối sống đề cao cảm xúc
đẹp.Không gian tinh tế của LEPAS L8 cũng là nơi trú ẩn cho những cảm xúc cá nhân. Thả mình trên hàng ghế tựa mềm mại như mây, điều chỉnh tựa lưng đến góc thoải mái nhất, chọn chế độ massage lý tưởng, và cảm nhận mọi căng thẳng dần tan biến. Hệ thống quản lý nhiệt độ nhanh chóng duy trì khoang
More news about: LEPAS
Dec 10, 2025, 09:00 ET Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
breast cancer and ovarian cancer, as well as additional cancer vaccines to address many intractable cancers, including high incidence malignancies in lung, colon, and prostate. These vaccine technologies focus on immunizing against "retired" proteins that have been found to be expressed in certain forms
More news about: Anixa Biosciences, Inc.
Dec 10, 2025, 09:00 ET Proven AI Gains in Radiology Lead WellSpan Health To Expand Aidoc aiOS™Across Enterprise
lines including cardiology, vascular surgery and neuroscience. The rollout also adds leading third-party clinical AI solutions natively through aiOS for lung nodules and breast lesions. These capabilities bridge identification and potential treatment, automatically routing patients with flagged findings to
More news about: Aidoc
Dec 10, 2025, 08:30 ET IceCure's ProSense® Cryoablation Featured in 4 Independent Breast Cancer Studies Presented at Radiological Society of America 2025 Annual Meeting
liquid nitrogen to create large lethal zones for maximum efficacy in tumor destruction in benign and cancerous lesions, including in the breast, kidney, lung, and liver.ProSense® enhances patient and provider value by accelerating recovery, reducing pain, surgical risks, and complications. With its
More news about: IceCure Medical
Dec 10, 2025, 08:00 ET Bantam Pharmaceutical Announces First Patient Treated in BTM-3566 Phase 1 Clinical Trial at Princess Margaret Cancer Centre in Toronto
includes patients with relapsed/refractory mature B-cell lymphomas. The solid tumor cohort includes a broad range of cancers such as head and neck, lung, gastroesophageal/gastrointestinal, colorectal, sarcomas, uterine, renal and bladder, among others."Princess Margaret Cancer Centre is excited
More news about: Bantam Pharmaceutical, LLC
Dec 10, 2025, 08:00 ET Indivumed and University of Rochester Medical Center expand collaboration for patient-centric discovery of novel therapeutics
entitiesThe collaboration initially focuses on advanced stages of solid cancers with a high medical need, such as colorectal (CRC), pancreatic (PDAC), lung, and breast cancer, with the potential to expand to other cancer types in the future. Insights gained through this partnership will advance Indivumed's
More news about: Indivumed GmbH
Dec 10, 2025, 08:00 ET Indivumed and University of Rochester Medical Center expand collaboration for patient-centric discovery of novel therapeutics
entitiesThe collaboration initially focuses on advanced stages of solid cancers with a high medical need, such as colorectal (CRC), pancreatic (PDAC), lung, and breast cancer, with the potential to expand to other cancer types in the future. Insights gained through this partnership will advance Indivumed's
More news about: Indivumed GmbH
Dec 10, 2025, 07:00 ET CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025
blood pumps already in the hospital (e.g. dialysis, continuous renal replacement therapy or CRRT, extracorporeal membrane oxygenation or ECMO, and heart-lung machines), where blood is repeatedly recirculated outside the body, through our cartridges where toxic substances are removed, and then back into the
More news about: Cytosorbents Corp
Dec 10, 2025, 06:45 ET "Supports Steady Energy, Focus, and Metabolic Balance" - Gundry MD MCT Wellness Wins A 2025 Nourish Award for Best Supplement
Gundry MD, Dr. Steven Gundry was one of the world's top cardiothoracic surgeons Currently, he's the medical director at The International Heart and Lung Institute and The Centers for Restorative Medicine in Palm Springs and Santa Barbara, California where he's spent the past 25 years helping people restore
More news about: Gundry MD
Dec 10, 2025, 06:00 ET IDEAYA Biosciences Announces IND Submission for IDE574, a Potential First-In-Class KAT6/7 Dual Inhibitor for Breast and Lung Cancers
proliferation and survival. Dual KAT6/7 inhibition by IDE574 disrupts tumor lineage identity and delivers robust anti-tumor activity in patient-derived lung and breast cancer xenograft models dependent upon lineage-specific transcription factor activity," said Michael White, Ph.D., Chief Scientific Officer
More news about: IDEAYA Biosciences, Inc.
Dec 09, 2025, 16:34 ET Equinox Expands Partnership with Function to Advance A New Standard of Health by Bringing Precision to Performance
accessible to more people. The advanced MRI can detect cancers, unruptured aneurysms, endometriosis, signs of stroke, etc., while the CT scan can identify lung cancer plaque in the heart, etc. All data is integrated into a single intelligent interface, giving each member a personalized view of their health
More news about: Equinox Group
Dec 09, 2025, 14:06 ET NCCN Summit Seeks to Improve Care for Veterans and First Responders with Cancer from Line-of-Duty Exposure
half of the 18 million are deemed eligible for care through Veterans Association Health Service," explained Jim Pantelas, Vietnam-Era War Veteran, Lung Cancer Survivor, and Patient Advocate. "What's more, exposure to one or more cancer-causing chemicals while on the job is not always considered
More news about: National Comprehensive Cancer Network
Dec 09, 2025, 13:11 ET California Department of Public Health Issues Urgent Health Advisory: Silicosis Cases Surge Among Artificial Stone Countertop Workers
a dramatic rise in silicosis cases among workers in the crystalline silica artificial stone countertop fabrication industry. Silicosis, an incurable lung disease caused by inhaling crystalline silica dust, is now officially a reportable disease in California, marking a pivotal step in the state's public
More news about: Brayton Purcell LLP
Dec 09, 2025, 09:30 ET Lung Cancer Research Foundation Announces Recipients of LCRF | Boehringer Ingelheim Early Investigator Awards
LCRF.org/research.About the Lung Cancer Research Foundation (LCRF)The Lung Cancer Research Foundation® (LCRF) is the leading nonprofit organization focused on funding innovative, high-reward research with the potential to extend survival and improve quality of life for people with lung cancer. LCRF's
More news about: Lung Cancer Research Foundation
Dec 09, 2025, 08:41 ET Yenos Analytical Launches the Yenos Test, First-of-its-Kind Multi-Cancer Early Detection Urine Test
reach of early detection. Recent studies with healthy samples and cancer samples from newly diagnosed stage I/II patients with prostate, pancreatic, lung, breast, ovarian and colorectal cancer showed a 97% sensitivity and 97% specificity, an unprecedented statistic in cancer diagnostics.1,2
More news about: Yenos Analytical LLC
Dec 09, 2025, 08:33 ET Korea University Researchers Develop Ultrasensitive Method to Detect Low-Frequency Cancer Mutations
clinically relevant cancer hotspots as EGFR and KRAS, MUTE-Seq improved concordance between plasma and tumor tissue in patients with non-small cell lung cancer and pancreatic cancer, including early-stage cases in which ctDNA levels are extremely low.Additional validation using cell-free DNA reference
More news about: Korea University College of Medicine
Dec 09, 2025, 07:30 ET Recordati Rare Diseases Announces Real-World Data on Long-Term Safety of ENJAYMO® (sutimlimab-jome) in Cold Agglutinin Disease and Cold Agglutinin Syndrome (CAD/CAS) at American Society of Hematology (ASH) Annual Meeting
SAE -- chest pain/stable angina -- was considered an unexpected sutimlimab-related SAE. There was one reported death in the cohort, due to low right lung pneumonia; this SAE was considered unrelated to sutimlimab.AEs of special interest (AESIs) in sutimlimab-treated patients included serious infections
More news about: Raliance Communications
Dec 09, 2025, 05:57 ET American Lung Association Launches Campaign to Help New England Residents Stay Healthy This Winter
GSK.About the American Lung AssociationThe American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic
More news about: American Lung Association
Dec 09, 2025, 05:00 ET Dizal Showcases its Strong Hematology Pipeline with New Data from Golidocitinib and Birelentinib at ASH 2025
internationally competitive portfolio. ZEGFROVY is the first and only small molecule drug approved in both the U.S. and China, for the treatment of non-small cell lung cancer with EGFR exon20 insertion mutations. Golidocitinib has been approved in China for the treatment of relapsed and refractory PTCL. To learn more
More news about: Dizal Pharmaceutical